Tirzepatide is FDA-approved for: Individuals with a body mass index of 30 (or 27 with weight-related conditions such as, type 2 diabetes mellitus, or metabolic resistance) Women managing Polycystic Ovary Syndrome (PCOS) Those with prediabetes or insulin resistance Anyone whos struggled with weight despite consistent efforts and is ready for a more targeted, science-backed solution If youre unsure whether you qualify, a simple consultation with a qualified provider can help determine if Tirzepatide aligns with your health goals
The Precision Peptide Genetic Test reveals predispositions in GLP-1 and related metabolic pathways, which may help contextualize individual treatment variability
Among the options is Wegovy, a leading semaglutide injection administered weekly, and the Wegovy pill for those averse to injections
Retatrutide clinical trials and pharmacology overview.
Other Uses: Often incorporated into body recomposition or cutting protocols when patients want fat loss support without appetite suppression, hormonal disruption, or nervous system stimulation
In: Said HM (ed) Physiology of the gastrointestinal tract